Huai Phen, MD
Orthopaedic Trauma · Bronx, NYNPI 1548793185
Payments from drug & device makers
What this record shows
This record is dominated by education: $12,535 of the $13,879 with a category attached, or 90.3%. Smith+Nephew accounts for 92.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $6,730 and has fallen 98.1% since, to $131 in 2025.
Across 25 payments — averaging $555.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$13K
- Stryker$822
- Nuvasive Specialized Orthopedics, Inc.$99
- Medical Device Business Services, Inc.$51
- Gotham Surgical Solutions & Devices, Inc.$17
What the payments were for
- Food & beverage$1,34410%
- Education$12,53590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 6 | $12,890 |
| Stryker | 15 | $822 |
| Nuvasive Specialized Orthopedics, Inc. | 1 | $99 |
| Medical Device Business Services, Inc. | 2 | $51 |
| Gotham Surgical Solutions & Devices, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVOS$297
- TRIGEN$188
- Taylor Spatial Frame$188
- TRIGEN InterTAN$188
- PELVIS II$175
- GAMMA$135
How this compares
$13,879 in reported general payments places this provider in the 70th percentile of 44 orthopaedic trauma providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 50 | $109 |
| Tramadol Hcl | 11 | $28 |
| Oxycodone Hcl | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Bronx
- Mani KahnBronx$14K
- David HelfetNew York$265K
- Philipp LeuchtNew York$260K
- Matthew SullivanEast Syracuse$63K
- Conor GarryNew York$63K
- Chima NwankwoBrooklyn$52K
- Brian PageNew York$43K
- Emil AzerEast Syracuse$42K
- Kathryn BarthNew York$38K
- Justin VaidaRochester$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.